Interaction of clonidine and clonidine analogs with human platelet α2-adrenergic receptors

Michael L. Steer*, Daphne Atlas

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Several new clonidine analogs were synthesized and their ability to inhibit [3H] phentolamine binding to human platelet α2-adrenergic receptors was tested. The order of potency and calculated dissociation constants for clonidine and its analogs were as follows: clonidine (0.020 ± 0.005 μM) > p-aminoclonidine (0.100 ± 0.010 μM) > hydroxy-phenacetyl-aminoclonidine (0.20 ± 0.03 μM) > p-dansyl clonidine (1.00 ± 0.20 μM) > t-boc-tyrosine clonidine (1.80 ± 0.60 μM). Thus, p-amino substitution reduces α2-adrenergic affinity in the platelet system. The effects of clonidine and its p-amino analogs on platelet adenylate cyclase were also evaluated. This enzyme is inhibited by epinephrine acting via α2-adrenergic receptors. Both clonidine and p-aminoclonidine cause slight inhibition of basal adenylate cyclase and reverse the inhibition induced by epinephrine. These observations indicate that clonidine is a partial agonist for platelet α2-adrenergic receptors.

Original languageEnglish
Pages (from-to)389-394
Number of pages6
JournalBiochimica et Biophysica Acta - General Subjects
Volume714
Issue number3
DOIs
StatePublished - 25 Feb 1982

Keywords

  • (Human platelet)
  • Clonidine
  • Receptor binding
  • Yohimbine
  • α-Adrenergic receptor

Fingerprint

Dive into the research topics of 'Interaction of clonidine and clonidine analogs with human platelet α2-adrenergic receptors'. Together they form a unique fingerprint.

Cite this